PMA device
Activa®, Percept and SenSight Deep Brain Stimulation Therapy System
Medtronic, Inc. · Stimulator, Electrical, Implanted, For Parkinsonian Symptoms (NHL, Class III) · First FDA decision Feb 20, 2025, newest Feb 20, 2025DystoniaEssential tremorParkinson's disease
Last checked: Nov 20, 2026Source: FDA, CMS, ClinicalTrials.gov, PubMed
FDA decisions
1
PMA pathway
Device trials
1
Naming "Activa Percept"
MAUDE reports
0
Brand "Activa Percept", since 2015
PubMed studies
0
Mentioning "Activa Percept"
AI summary across all sources
Written by AI from the FDA, CMS, ClinicalTrials.gov, MAUDE and PubMed data on this page, plus web searches for payment facts.
Product review deck
A slide deck reviewing Activa®, Percept and SenSight Deep Brain Stimulation Therapy System
About ten slides on the technology, clinical evidence, regulatory history and commercialization, built with AI from the data on this page and web research, with sources. Download it as PowerPoint to edit or as PDF to share.
- Executive summary and key facts
- Technology
- Clinical evidence and trials
- Regulatory history and safety
- Reimbursement, market and competition
- Risks, outlook and sources
AI-written from public data and may contain mistakes. Check each fact against its source before relying on it. Not investment, legal, reimbursement or medical advice.
FDA decisions
The newest 1 of 1 decisions filed under this name.
P960009-S478 · Decided Feb 20, 2025 · 309 days after receipt · Panel Track
Device type: Stimulator, electrical, implanted, for parkinsonian symptoms (NHL) · Neurology & Neurosurgery
Medicare coverage
National and local coverage documents whose titles match this device or its device type. Payment add-ons (NTAP, pass-through, TCET) and likely codes are covered in the summary above.
- Transcutaneous Electrical Nerve Stimulators (TENS) - RETIREDNational determinationOn the books280.13Updated Jun 7, 2024
- Electrical Nerve StimulatorsNational determinationOn the books160.7Updated Aug 17, 2023
- Non-Implantable Pelvic Floor Electrical StimulatorNational determinationOn the books230.8Updated Aug 17, 2023
- Transcutaneous Electrical Nerve Stimulators (TENS)Local determinationIn effectL33802CGS Administrators, LLCUpdated Dec 7, 2023
Clinical trials
Device studies on ClinicalTrials.gov that name "Activa Percept", any status and sponsor, newest update first.
MedtronicNeuroNot on our public-company list
NCT03900468 · 29 participants · Start Mar 5, 2020 · Primary completion Oct 15, 2025
Device: Activa™ PC and Percept™ PC Neurostimulation Systems · For: Epilepsy
Sites: Los Angeles, California; San Francisco, California; Atlanta, Georgia · 8 sites in all
Adverse event reports (MAUDE)
Reports received since 2015 naming the brand "Activa Percept", and for the whole product code for context.
This brand
0 reports: 0 malfunction, 0 injury, 0 death
Whole product code NHL
1,848 reports: 183 malfunction, 1,620 injury, 43 death
Newest reports for this brand
No MAUDE reports name this brand.
Recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
- Medtronic 1x4 Pocket Adaptor Kit for Deep Brain Stimulation, Model 64001; Stimulator, electrical, implanted, for parkinsonian tremorOpen, Classified
Z-2240-2026 · Started May 13, 2026 · Posted by FDA May 28, 2026
Reason given: A limited number of Pocket Adaptor Kits, Model 64001 and 64002, are labeled with incorrect Use-By-Dates.
Cause as FDA categorized it: Under Investigation by firm · Device type: Stimulator, Electrical, Implanted, For Parkinsonian Tremor (MHY)
- Medtronic 2x4 Pocket Adaptor Kit for Deep Brain Stimulation, Model 64002; Stimulator, electrical, implanted, for parkinsonian tremorOpen, Classified
Z-2241-2026 · Started May 13, 2026 · Posted by FDA May 28, 2026
Reason given: A limited number of Pocket Adaptor Kits, Model 64001 and 64002, are labeled with incorrect Use-By-Dates.
Cause as FDA categorized it: Under Investigation by firm · Device type: Stimulator, Electrical, Implanted, For Parkinsonian Tremor (MHY)
Z-0206-2025 · Started Sep 24, 2024 · Posted by FDA Oct 23, 2024
Reason given: A limited number of Percept RC Implantable Neurostimulators (INS), Model B35300 will not be able to communicate with the A610 DBS Clinician Programmer Application upon use and an "Invalid Device" message will appear.
Cause as FDA categorized it: Under Investigation by firm · Device type: Stimulator, Electrical, Implanted, For Parkinsonian Tremor (MHY)
17 more recall records with a free account
Published research
The most relevant PubMed records for "Activa Percept"[tiab]. The summary above synthesizes these.
No PubMed record mentions this device by name.
Other devices of this type
Also filed under product code NHL.
- Vercise Genus DBS System, Vercise Gevia DBS System, Vercise PC DBS SystemBoston Scientific Corp · PMA 2024
- Vercise Deep Brain Stimulation (Dbs) SystemBoston Scientific Corp · PMA 2026
- Vercise PC DBS System, Vercise Gervia DBS System, Vercise Genus DBS SystemBoston Scientific Corp · PMA 2024
- Vercise DBS System / Vercise PC DBS SystemBoston Scientific Corp · PMA 2018
- Vercise DBS ControllerBoston Scientific Corp · PMA 2025
- Vercise S8 AdapterBoston Scientific Corp · PMA 2023
- Vercise Genus Deep Brain Stimulation (DBS) SystemBoston Scientific Corp · PMA 2021
- Vercise Gevia DBS System and Directional Lead-only SystemBoston Scientific Corp · PMA 2019
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.